spacer
spacer

PDBsum entry 4tpt

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transferase/transferase inhibitor PDB id
4tpt

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
279 a.a.
Ligands
35H ×2
Waters ×30
PDB id:
4tpt
Name: Transferase/transferase inhibitor
Title: Crystal structure of the human limk2 kinase domain in complex with a non-atp competitive inhibitor
Structure: Lim domain kinase 2. Chain: a, b. Fragment: kinase domain (unp residues 330-632). Synonym: limk-2. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: limk2. Expressed in: unidentified baculovirus. Expression_system_taxid: 10469
Resolution:
2.60Å     R-factor:   0.223     R-free:   0.274
Authors: N.C.Goodwin,G.Cianchetta,B.L.Hamman,H.A.Burgoon,J.Healy,S.Mabon, E.D.Strobel,S.Wang,D.B.Rawlins
Key ref: N.C.Goodwin et al. (2015). Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation. Acs Med Chem Lett, 6, 53-57. PubMed id: 25589930 DOI: 10.1021/ml500242y
Date:
09-Jun-14     Release date:   22-Oct-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P53671  (LIMK2_HUMAN) -  LIM domain kinase 2 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
638 a.a.
279 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.11.1  - non-specific serine/threonine protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/ml500242y Acs Med Chem Lett 6:53-57 (2015)
PubMed id: 25589930  
 
 
Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation.
N.C.Goodwin, G.Cianchetta, H.A.Burgoon, J.Healy, R.Mabon, E.D.Strobel, J.Allen, S.Wang, B.D.Hamman, D.B.Rawlins.
 
  ABSTRACT  
 
The first allosteric, type III inhibitor of LIM-kinase 2 (LIMK2) is reported. A series of molecules that feature both an N-phenylsulfonamide and tertiary amide were not only very potent at LIMK2 but also were extremely selective against a panel of other kinases. Enzymatic kinetic studies showed these molecules to be noncompetitive with ATP, suggesting allosteric inhibition. X-ray crystallography confirmed that these sulfonamides are a rare example of a type III kinase inhibitor that binds away from the highly conserved hinge region and instead resides in the hydrophobic pocket formed in the DFG-out conformation of the kinase, thus accounting for the high level of selectivity observed.
 

 

spacer

spacer